Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07479901

Investigation of the Effect of the Atherogenic Index on the Therapeutic Response to Tadalafil in Patients With Vascular Erectile Dysfunction

Sponsor: Taksim Egitim ve Arastirma Hastanesi

View on ClinicalTrials.gov

Summary

This study aims to investigate the relationship between the atherogenic index of plasma (AIP) and the therapeutic response to daily tadalafil 5 mg treatment in patients diagnosed with vascular erectile dysfunction (VED). AIP is considered a marker of atherogenic dyslipidemia and subclinical atherosclerosis and is calculated using the formula log10 (triglycerides/HDL-C). Since vascular abnormalities play a major role in the pathophysiology of erectile dysfunction, AIP may reflect underlying vascular risk and potentially predict treatment outcomes. In this prospective observational study, patients with vascular erectile dysfunction will receive tadalafil 5 mg once daily for one month, and treatment response will be evaluated by comparing clinical parameters before and after therapy.

Key Details

Gender

MALE

Age Range

40 Years - Any

Study Type

OBSERVATIONAL

Enrollment

132

Start Date

2025-10-12

Completion Date

2026-04-20

Last Updated

2026-03-18

Healthy Volunteers

No

Locations (1)

Taksim Training and Research Hospital, Istanbul

Istanbul, beyoğlu, Turkey (Türkiye)